Theriva Biologics, Inc. Fair Value Adjustment of Warrants
Theriva Biologics, Inc. (TOVX) reported Fair Value Adjustment of Warrants of $0 for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-20.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2020-02-20
- Theriva Biologics, Inc. fair value adjustment of warrants for the quarter ending 2019-12-31 was $0.00.
- Theriva Biologics, Inc. fair value adjustment of warrants for the quarter ending 2019-09-30 was $0.00.
- Theriva Biologics, Inc. fair value adjustment of warrants for the quarter ending 2019-06-30 was $0.00.
- Theriva Biologics, Inc. fair value adjustment of warrants for the quarter ending 2019-03-31 was $0.00.
- Theriva Biologics, Inc. fair value adjustment of warrants for fiscal 2019 was $0.00.
- Theriva Biologics, Inc. fair value adjustment of warrants for fiscal 2018 was -$4.08M.
- Theriva Biologics, Inc. fair value adjustment of warrants for fiscal 2017 was -$10.74M.
- Theriva Biologics, Inc. fair value adjustment of warrants for fiscal 2016 was -$11.41M, a 399.45% decline from fiscal 2015.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-20 | $0.00 derived: sum of 2 quarters · filed 2020-02-20 | $0.00 derived: sum of 3 quarters · filed 2020-02-20 | $0.00 10-K · filed 2020-02-20 |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-04 | $0.00 derived: sum of 2 quarters · filed 2019-11-04 | $0.00 10-Q · filed 2019-11-04 | -$19.00K derived: sum of 4 quarters · filed 2020-02-20 |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-08 | $0.00 10-Q · filed 2019-08-08 | -$19.00K derived: sum of 3 quarters · filed 2020-02-20 | -$645.00K derived: sum of 4 quarters · filed 2020-02-20 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-08 | -$19.00K derived: sum of 2 quarters · filed 2020-02-20 | -$645.00K derived: sum of 3 quarters · filed 2020-02-20 | -$1.43M derived: sum of 4 quarters · filed 2020-02-20 |
| 2018-12-31 | -$19.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-20 | -$645.00K derived: sum of 2 quarters · filed 2020-02-20 | -$1.43M derived: sum of 3 quarters · filed 2020-02-20 | -$4.08M 10-K · filed 2020-02-20 |
| 2018-09-30 | -$626.00K 10-Q · filed 2019-11-04 | -$1.41M derived: sum of 2 quarters · filed 2019-11-04 | -$4.06M 10-Q · filed 2019-11-04 | -$12.64M derived: sum of 4 quarters · filed 2019-11-04 |
| 2018-06-30 | -$783.00K 10-Q · filed 2019-08-08 | -$3.44M 10-Q · filed 2019-08-08 | -$12.02M derived: sum of 3 quarters · filed 2019-08-08 | -$6.93M derived: sum of 4 quarters · filed 2019-08-08 |
| 2018-03-31 | -$2.65M 10-Q · filed 2019-05-08 | -$11.24M derived: sum of 2 quarters · filed 2019-05-08 | -$6.14M derived: sum of 3 quarters · filed 2019-05-08 | -$8.30M derived: sum of 4 quarters · filed 2019-05-08 |
| 2017-12-31 | -$8.58M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | -$3.49M derived: sum of 2 quarters · filed 2019-02-27 | -$5.65M derived: sum of 3 quarters · filed 2019-02-27 | -$10.74M 10-K · filed 2019-02-27 |
| 2017-09-30 | $5.09M 10-Q · filed 2018-11-08 | $2.93M derived: sum of 2 quarters · filed 2018-11-08 | -$2.16M 10-Q · filed 2018-11-08 | -$9.89M derived: sum of 4 quarters · filed 2018-11-08 |
| 2017-06-30 | -$2.16M 10-Q · filed 2018-08-08 | -$7.25M 10-Q · filed 2018-08-08 | -$14.98M derived: sum of 3 quarters · filed 2018-08-08 | -$15.65M derived: sum of 4 quarters · filed 2018-08-08 |
| 2017-03-31 | -$5.09M 10-Q · filed 2018-05-08 | -$12.82M derived: sum of 2 quarters · filed 2018-05-08 | -$13.49M derived: sum of 3 quarters · filed 2018-05-08 | -$17.00M derived: sum of 4 quarters · filed 2018-05-08 |
| 2016-12-31 | -$7.73M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | -$8.40M derived: sum of 2 quarters · filed 2018-02-22 | -$11.91M derived: sum of 3 quarters · filed 2018-02-22 | -$11.41M 10-K · filed 2018-02-22 |
| 2016-09-30 | -$666.00K 10-Q · filed 2017-11-01 | -$4.18M derived: sum of 2 quarters · filed 2017-11-01 | -$3.68M 10-Q · filed 2017-11-01 | -$3.78M derived: sum of 4 quarters · filed 2018-02-22 |
| 2016-06-30 | -$3.51M 10-Q · filed 2017-08-03 | -$3.02M 10-Q · filed 2017-08-03 | -$3.11M derived: sum of 3 quarters · filed 2018-02-22 | -$7.25M derived: sum of 4 quarters · filed 2018-02-22 |
| 2016-03-31 | $498.00K 10-Q · filed 2017-05-04 | $403.00K derived: sum of 2 quarters · filed 2018-02-22 | -$3.74M derived: sum of 3 quarters · filed 2018-02-22 | $157.00K derived: sum of 4 quarters · filed 2018-02-22 |
| 2015-12-31 | -$95.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | -$4.24M derived: sum of 2 quarters · filed 2018-02-22 | -$341.00K derived: sum of 3 quarters · filed 2018-02-22 | $3.81M 10-K · filed 2018-02-22 |
| 2015-09-30 | -$4.14M 10-Q · filed 2016-11-01 | -$246.00K derived: sum of 2 quarters · filed 2016-11-01 | $3.91M 10-Q · filed 2016-11-01 | $3.29M derived: sum of 4 quarters · filed 2017-03-02 |
| 2015-06-30 | $3.90M 10-Q · filed 2016-08-03 | $8.05M 10-Q · filed 2016-08-03 | $7.43M derived: sum of 3 quarters · filed 2017-03-02 | $7.43M derived: sum of 4 quarters · filed 2017-03-02 |
| 2015-03-31 | $4.15M 10-Q · filed 2016-05-05 | $3.53M derived: sum of 2 quarters · filed 2017-03-02 | $3.53M derived: sum of 3 quarters · filed 2017-03-02 | $3.53M derived: sum of 4 quarters · filed 2017-03-02 |
| 2014-12-31 | -$620.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-02 | -$620.00K derived: sum of 2 quarters · filed 2017-03-02 | -$620.00K derived: sum of 3 quarters · filed 2017-03-02 | -$620.00K 10-K · filed 2017-03-02 |
| 2014-09-30 | $0.00 10-Q · filed 2015-11-05 | $0.00 derived: sum of 2 quarters · filed 2015-11-05 | $0.00 10-Q · filed 2015-11-05 | |
| 2014-06-30 | $0.00 10-Q · filed 2015-08-10 | $0.00 10-Q · filed 2015-08-10 | ||
| 2014-03-31 | $0.00 10-Q · filed 2015-05-11 | |||
| 2013-12-31 | $0.00 10-K · filed 2016-03-10 | |||
| 2012-12-31 | $0.00 10-K · filed 2015-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |